India, Oct. 7 -- In the shadow of India's ongoing battle against substandard pharmaceuticals, the Union Health Ministry's recent high-level meeting highlights a grim reality that the quality of cough syrups, a staple in many households, cannot be taken for granted. With reports of child deaths in Madhya Pradesh and Rajasthan allegedly tied to contaminated formulations though investigations in Rajasthan have preliminarily cleared the syrups the spotlight is on enforcing the Revised Schedule M guidelines for Good Manufacturing Practices (GMP). The national imperative resonates deeply in Jammu and Kashmir, particularly the Kashmir Valley, where harsh winters amplify respiratory ailments, turning a simple cough into a potential health crisis. ...